Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry
✍ Scribed by J.-E. Gottenberg; P. Ravaud; T. Bardin; P. Cacoub; A. Cantagrel; B. Combe; M. Dougados; R. M. Flipo; B. Godeau; L. Guillevin; X. Le Loët; E. Hachulla; T. Schaeverbeke; J. Sibilia; G. Baron; X. Mariette
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 106 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective For patients with rheumatoid arthritis (RA), yearly influenza vaccination is recommended. However, its efficacy in patients treated with rituximab is unknown. The objectives of this study were to investigate the efficacy of influenza vaccination in RA patients treated with
## Abstract ## Objective To study the specific effects of rituximab treatment on the synovium in patients with rheumatoid arthritis (RA) early after initiation of treatment. ## Methods Seventeen RA patients underwent an arthroscopic synovial biopsy procedure directly before and 1 month after rec